Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda Oyang

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|June 22, 2018
Induction of Pro-Inflammatory Response via Activated Macrophage-Mediated NF-κB and STAT3 Pathways in Gastric Cancer CellsYujuan Zhou, Longzheng Xia, Qiang Liu, et al.
Oncotargets and Therapy|March 12, 2021
Biological Function of HYOU1 in Tumors and Other DiseasesShan Rao, Linda Oyang, Jiaxin Liang, et al.
Cancer Science|November 12, 2022
Rac1 promotes the reprogramming of glucose metabolism and the growth of colon cancer cells through upregulating SOX9Jiaxin Liang, Qiang Liu, Longzheng Xia, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 25, 2019
The roles of glucose metabolic reprogramming in chemo- and radio-resistanceJinguan Lin, Longzheng Xia, Jiaxin Liang, et al.
Genes & Diseases|August 18, 2025
The regulatory role and mechanism of energy metabolism and immune response in head and neck cancerHaofan Li, Qiu Peng, Linda Oyang, et al.
Journal of Hematology & Oncology|February 19, 2025
Noncoding RNA-encoded peptides in cancer: biological functions, posttranslational modifications and therapeutic potentialShiming Tan, Wenjuan Yang, Zongyao Ren, et al.
Experimental & Molecular Medicine|July 2, 2023
Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potentialXuemeng Xu, Qiu Peng, Xianjie Jiang, et al.
Journal of Cancer|April 25, 2020
MiRNAs in Radiotherapy Resistance of Nasopharyngeal CarcinomaYutong Tian, Lu Tang, Pin Yi, et al.
Cancer Communications (London, England)|September 21, 2024
Altered glycosylation in cancer: molecular functions and therapeutic potentialXuemeng Xu, Qiu Peng, Xianjie Jiang, et al.
International Journal of Oncology|February 14, 2025
Long non‑coding RNA ABHD11‑AS1 inhibits colorectal cancer progression through interacting with EGFR to suppress the EGFR/ERK signaling pathwayShiming Tan, Shizhen Li, Longzheng Xia, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|June 22, 2018
Induction of Pro-Inflammatory Response via Activated Macrophage-Mediated NF-κB and STAT3 Pathways in Gastric Cancer CellsYujuan Zhou, Longzheng Xia, Qiang Liu, et al.
Oncotargets and Therapy|March 12, 2021
Biological Function of HYOU1 in Tumors and Other DiseasesShan Rao, Linda Oyang, Jiaxin Liang, et al.
Cancer Science|November 12, 2022
Rac1 promotes the reprogramming of glucose metabolism and the growth of colon cancer cells through upregulating SOX9Jiaxin Liang, Qiang Liu, Longzheng Xia, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 25, 2019
The roles of glucose metabolic reprogramming in chemo- and radio-resistanceJinguan Lin, Longzheng Xia, Jiaxin Liang, et al.
Genes & Diseases|August 18, 2025
The regulatory role and mechanism of energy metabolism and immune response in head and neck cancerHaofan Li, Qiu Peng, Linda Oyang, et al.
Journal of Hematology & Oncology|February 19, 2025
Noncoding RNA-encoded peptides in cancer: biological functions, posttranslational modifications and therapeutic potentialShiming Tan, Wenjuan Yang, Zongyao Ren, et al.
Experimental & Molecular Medicine|July 2, 2023
Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potentialXuemeng Xu, Qiu Peng, Xianjie Jiang, et al.
Journal of Cancer|April 25, 2020
MiRNAs in Radiotherapy Resistance of Nasopharyngeal CarcinomaYutong Tian, Lu Tang, Pin Yi, et al.
Cancer Communications (London, England)|September 21, 2024
Altered glycosylation in cancer: molecular functions and therapeutic potentialXuemeng Xu, Qiu Peng, Xianjie Jiang, et al.
International Journal of Oncology|February 14, 2025
Long non‑coding RNA ABHD11‑AS1 inhibits colorectal cancer progression through interacting with EGFR to suppress the EGFR/ERK signaling pathwayShiming Tan, Shizhen Li, Longzheng Xia, et al.
Pageof 5